Rybelsus is an oral GLP-1 receptor agonist licensed in the UK for type 2 diabetes treatment in adults
The concept of off-label prescribing exists throughout medicine, and GLP-1 medications are no exception
Standard research protocol is 2 mg/day for 6+ months to reach plateau VAT reduction
BodyTite represents a significant advancement for post-GLP-1 patients because it addresses both fat removal and skin laxity simultaneously
Khan SA, Priyamvada S, Khan W, Khan S, Farooq N, and Yusufi ANK
The Mounjaro weight loss pen is supported by clinical research showing meaningful weight reduction when used under a doctors supervisionespecially for people with obesity, or those who have tried diet and exercise but still struggle to achieve sustainable results